Nautilus Biotechnology Inc (NAUT)
2.69
+0.02
(+0.75%)
USD |
NASDAQ |
May 03, 16:00
2.69
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology Market Cap: 336.96M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 336.96M |
| May 02, 2024 | 334.46M |
| May 01, 2024 | 348.24M |
| April 30, 2024 | 318.17M |
| April 29, 2024 | 321.93M |
| April 26, 2024 | 311.91M |
| April 25, 2024 | 295.63M |
| April 24, 2024 | 300.64M |
| April 23, 2024 | 311.91M |
| April 22, 2024 | 303.14M |
| April 19, 2024 | 308.15M |
| April 18, 2024 | 293.12M |
| April 17, 2024 | 304.39M |
| April 16, 2024 | 315.67M |
| April 15, 2024 | 308.15M |
| April 12, 2024 | 309.40M |
| April 11, 2024 | 329.45M |
| April 10, 2024 | 320.68M |
| April 09, 2024 | 329.45M |
| April 08, 2024 | 338.22M |
| April 05, 2024 | 334.46M |
| April 04, 2024 | 330.70M |
| April 03, 2024 | 346.98M |
| April 02, 2024 | 339.47M |
| April 01, 2024 | 375.80M |
| Date | Value |
|---|---|
| March 28, 2024 | 367.79M |
| March 27, 2024 | 346.52M |
| March 26, 2024 | 326.51M |
| March 25, 2024 | 331.51M |
| March 22, 2024 | 331.51M |
| March 21, 2024 | 345.27M |
| March 20, 2024 | 341.52M |
| March 19, 2024 | 325.26M |
| March 18, 2024 | 327.76M |
| March 15, 2024 | 320.25M |
| March 14, 2024 | 312.75M |
| March 13, 2024 | 330.26M |
| March 12, 2024 | 317.75M |
| March 11, 2024 | 301.49M |
| March 08, 2024 | 372.79M |
| March 07, 2024 | 367.79M |
| March 06, 2024 | 335.26M |
| March 05, 2024 | 326.51M |
| March 04, 2024 | 336.51M |
| March 01, 2024 | 340.27M |
| February 29, 2024 | 336.51M |
| February 28, 2024 | 350.27M |
| February 27, 2024 | 367.79M |
| February 26, 2024 | 340.27M |
| February 23, 2024 | 351.53M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
193.32M
Minimum
Dec 16 2022
1.364B
Maximum
Jun 10 2021
460.52M
Average
375.96M
Median
Market Cap Benchmarks
| Amicus Therapeutics Inc | 3.072B |
| Geron Corp | 2.331B |
| TG Therapeutics Inc | 2.502B |
| Editas Medicine Inc | 463.88M |
| G1 Therapeutics Inc | 234.38M |
Market Cap Related Metrics
| Price to Book Value | 1.351 |
| Price | 2.69 |
| Earnings Yield | -20.45% |